Active ingredientImatinibCat. No. P-I026-001CAS 152459-95-5Family · Pharmaceutical analytical standards
Imatinib
An inhibitor of BCR-ABL tyrosine kinase, the abnormal protein that drives chronic myeloid leukaemia. It was approved in the United States in 2001 in record time, after clinical trials led by oncologist Brian Druker. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Its target arises from the Philadelphia chromosome, discovered in 1960 by Peter Nowell and David Hungerford and named after the city where they worked.
Go to the active ingredient →Active ingredientImatinibCat. No. P-I026-001CAS 152459-95-5
Pharmacopoeial impurityImatinib EP Impurity ACat. No. P-I026-002CAS 123367-26-0
Pharmacopoeial impurityImatinib EP Impurity BCat. No. P-I026-003CAS 581076-65-5
Pharmacopoeial impurityImatinib EP Impurity CCat. No. P-I026-004CAS 404844-02-6
Pharmacopoeial impurityImatinib EP Impurity D ChlorideCat. No. P-I026-006
Pharmacopoeial impurityImatinib EP Impurity FCat. No. P-I026-007CAS 152460-10-1
Pharmacopoeial impurityImatinib EP Impurity HCat. No. P-I026-008CAS 350-03-8
Pharmacopoeial impurityImatinib EP Impurity JCat. No. P-I026-009CAS 571186-91-9
Isotopically labelledImatinib EP Impurity C-d8Cat. No. P-I026-010CAS 1185103-28-9
Isotopically labelledImatinib-d8Cat. No. P-I026-011CAS 1092942-82-9
Isotopically labelledN-Nitroso Imatinib-d8Cat. No. P-I026-012
NitrosamineN-Desmethyl N-Nitroso ImatinibCat. No. P-I026-013CAS 2816369-80-7
NitrosamineN-Nitroso ImatinibCat. No. P-I026-014
NitrosamineN-Nitroso Imatinib EP Impurity C-1Cat. No. P-I026-015
NitrosamineN-Nitroso Imatinib EP Impurity FCat. No. P-I026-016
NitrosamineN-Nitroso Imatinib EP Impurity JCat. No. P-I026-017
NitrosamineN-Nitroso Imatinib formateCat. No. P-I026-018
Impurity1-(2-Methyl-5-nitrophenyl)guanidine hydrochlorideCat. No. P-I026-019CAS 1207534-99-3
Impurity1-(2-Methyl-5-nitrophenyl)guanidine NitrateCat. No. P-I026-020CAS 152460-08-7
ImpurityImatinib Impurity 1Cat. No. P-I026-021CAS 514209-40-6
Impurity2-Methyl-4-nitrophenylguanidine NitrateCat. No. P-I026-022CAS 796738-73-3
ImpurityImatinib Impurity 2Cat. No. P-I026-023CAS 152460-09-8
ImpurityImatinib Impurity 3Cat. No. P-I026-024CAS 66521-53-7
Impurity3-Chloro-4-methylbenzoyl chlorideCat. No. P-I026-025CAS 21900-30-1
ImpurityImatinib Impurity 4Cat. No. P-I026-026CAS 106261-48-7
ImpurityImatinib Impurity 5Cat. No. P-I026-027CAS 404844-11-7
Impurity4-(Dibromomethyl)benzonitrileCat. No. P-I026-028CAS 67013-55-2
Impurity4-(Dichloromethyl)benzonitrileCat. No. P-I026-029CAS 74231-65-5
Impurity4-(Dichloromethyl)benzoyl chlorideCat. No. P-I026-030CAS 36747-64-5
ImpurityImatinib Impurity 6Cat. No. P-I026-031CAS 1321600-77-4![4-Des[(4-Methyl-1-piperazinyl)methyl]-4-formyl Imatinib](https://img.vitasanlabs.com/vsl-struct/P-I026-032.svg?v=41e934f030)
Impurity4-Des[(4-Methyl-1-piperazinyl)methyl]-4-formyl ImatinibCat. No. P-I026-032CAS 1219828-35-9
ImpurityImatinib Impurity 7Cat. No. P-I026-033CAS 152459-96-6
ImpurityEthyl MethanesulfonateCat. No. P-I026-034CAS 62-50-0
Active ingredientImatinib MesylateCat. No. P-I026-035CAS 220127-57-1
ImpurityImatinib Impurity 8Cat. No. P-I026-036CAS 1356565-46-2
ImpurityImatinib (Piperazine)-N1-OxideCat. No. P-I026-037CAS 938082-57-6
ImpurityImatinib Carboxylic Impurity DihydrochlorideCat. No. P-I026-038CAS 106261-49-8
ImpurityImatinib Impurity 9Cat. No. P-I026-039
ImpurityImatinib Impurity 11Cat. No. P-I026-041
ImpurityImatinib Impurity 12Cat. No. P-I026-042
ImpurityImatinib Impurity 13Cat. No. P-I026-043
ImpurityImatinib Impurity 14Cat. No. P-I026-044
ImpurityImatinib Impurity 16Cat. No. P-I026-046
ImpurityImatinib Impurity 17Cat. No. P-I026-047
ImpurityImatinib Impurity 18 HydrochlorideCat. No. P-I026-049CAS 1170909-72-4
ImpurityImatinib Impurity 19Cat. No. P-I026-050
ImpurityImatinib Impurity 20Cat. No. P-I026-051
ImpurityImatinib Impurity 21Cat. No. P-I026-052
ImpurityImatinib Impurity 22Cat. No. P-I026-053
ImpurityImatinib Impurity 23Cat. No. P-I026-054CAS 1407124-83-7
ImpurityImatinib Impurity 24Cat. No. P-I026-055CAS 942514-62-7
ImpurityImatinib Impurity 25Cat. No. P-I026-056
ImpurityImatinib Impurity 26 DihydrochlorideCat. No. P-I026-057
ImpurityImatinib Impurity 27 DihydrochlorideCat. No. P-I026-058
ImpurityImatinib Impurity 28Cat. No. P-I026-059CAS 1232063-00-1
ImpurityImatinib Impurity 29Cat. No. P-I026-061CAS 1365802-18-1
ImpurityImatinib Impurity 30Cat. No. P-I026-063
ImpurityImatinib Impurity 31Cat. No. P-I026-064
ImpurityN-Formyl Imatinib EP Impurity FCat. No. P-I026-065
ImpurityImatinib Meta-methyl-piperazine ImpurityCat. No. P-I026-067CAS 1246819-59-9
ImpurityImatinib N1,N4-DioxideCat. No. P-I026-068CAS 571186-93-1
ImpurityImatinib Para-PPA ImpurityCat. No. P-I026-069CAS 1026753-54-7
ImpurityImatinib Pyridine N-OxideCat. No. P-I026-070CAS 571186-92-0
ImpurityImatinib Impurity 32Cat. No. P-I026-071CAS 2118894-75-8
ImpurityIsopropyl MethanesulfonateCat. No. P-I026-072CAS 926-06-7
ImpurityImatinib Impurity 33Cat. No. P-I026-073CAS 314268-40-1
ImpurityImatinib Impurity 34Cat. No. P-I026-074CAS 1802325-93-4
ImpurityImatinib Impurity 35Cat. No. P-I026-075CAS 796738-71-1
ImpurityImatinib Impurity 36Cat. No. P-I026-076CAS 1032314-73-0
ImpurityN-(2-Methyl-5-aminophenyl)guanidineCat. No. P-I026-077CAS 581076-64-4
ImpurityImatinib Impurity 37Cat. No. P-I026-078CAS 475587-23-6
ImpurityImatinib Impurity 38Cat. No. P-I026-079CAS 112696-91-0
ImpurityImatinib Impurity 39Cat. No. P-I026-080CAS 1321600-78-5
ImpurityImatinib Impurity 40Cat. No. P-I026-081CAS 2753049-11-3
ImpurityN-Formyl ImatinibCat. No. P-I026-082CAS 1436868-85-7No product matches your search.
EDQM standards 5
The official European Pharmacopoeia standards for this family.
ImpurityImatinib impurity A CRSEDQM code Y0001695Family ImatinibImpurityImatinib impurity F CRSEDQM code Y0001693Family ImatinibImpurityImatinib impurity H CRSEDQM code Y0001694Family ImatinibReference substanceImatinib mesilate CRSEDQM code Y0001691Family ImatinibNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.